← All supplements
Limited evidenceGut health

Wormwood (Artemisia Absinthium)

A bitter herb whose only reasonable human trial is in Crohn's disease, not parasites. The traditional antiparasitic use has no controlled human evidence, and thujone sets a real ceiling on dose and duration.

Evidence last reviewed: August 2026

What the science says

  • Crohn's disease Limited evidence

    A double-blind placebo-controlled study in about 40 patients found wormwood added to steroids allowed steroid tapering with fewer symptoms. It is a single small trial from one group and has not been independently replicated.

  • Inflammatory bowel disease generally Limited evidence

    A systematic review of herbal therapy in inflammatory bowel disease included the wormwood trials and judged the overall evidence insufficient to recommend such treatments.

  • Intestinal parasites Limited evidence

    There is no controlled human trial of wormwood for intestinal parasites. The antimalarial artemisinin comes from a different species, Artemisia annua, and is a different compound.

Dosage & safety

Studied doseThe Crohn's trial used 750 mg of dried wormwood powder three times daily for six weeks. Thujone-free extracts are preferable for anything longer.
SafetyThujone is neurotoxic at high intake and can trigger seizures; a regulatory risk assessment concluded exposure from some wormwood products can approach levels of concern. Avoid in pregnancy, breastfeeding, epilepsy and kidney disease, and do not use continuously for more than a few weeks.

Scientific references

Where to buy

Referral link — this site may earn a commission on purchases.

Related in Gut health